Strategies to limit dysmyelination during secondary degeneration following neurotrauma

Strategies to limit dysmyelination during secondary degeneration following neurotrauma

Following trauma to the central nervous system (CNS), cells in the lesion site die rapidly. In addition, neurons and glia beyond the initial lesion are vulnerable. These cells can undergo delayed death due to metabolic events that follow the initial trauma, via mechanisms thought to be triggered by glutamate-induced excitotoxicity and Ca2+overload, leading to mitochondrial dysfunction, associated with increased oxidative stress (Camello-Almaraz et al., 2006; Peng and Jou, 2010). The resultant death of areas of grey and white matter adjacent to the lesion site is termed secondary degeneration, and is a feature of brain and spinal cord injury (Park et al., 2004; Giaume et al., 2007). Secondary degeneration contributes substantially to functional loss following neurotrauma (Profyris et al., 2004; Farkas and Povlishock, 2007) and rescuing this intact, but vulnerable, tissue is considered critical to minimising adverse sequelae and improving long term functional outcomes after CNS trauma (Fehlings et al., 2012). However, our understanding of many of the metabolic events thought to contribute to secondary degeneration is based largely on in vitro studies (Khodorov, 2004; Tretter et al., 2007; Peng and Jou, 2010) and there is a need to con fi rm the relevance of these mechanisms in vivo, as well as their structural and functional consequences.

To study and develop treatments for secondary degeneration, it is essential to have a reproducible in vivo model system that simulates the complex events that occur in humans and allows statistical verification of tissue rescue and functional improvements. Levkovitch-Verbin and colleagues developed an elegant partial optic nerve transection model in which only the dorsal optic nerve is injured, allowing spatial separation of the dorsal primary injury from ventral optic nerve white matter vulnerable to secondary degeneration (Levkovitch-Verbin et al., 2001; Levkovitch-Verbin et al., 2003; Blair et al., 2005). We and others have built upon these studies and this brief review describes some of this work further characterising metabolic and structural features of secondary degeneration following partial optic nerve transection, with particular reference to dysmyelination, and assessment of ef fi cacy of treatment strategies to limit these changes.

Ca2+changes and oxidative stress during secondary degeneration in vivo

Altered distribution of Ca2+ions is thought to be a key early event in secondary degeneration, but these fi ne-scale changes are difficult to track in vivo. Using nanoscale secondary ion mass spectrometry (NanoSIMS) we have quanti fi ed changes in calcium (Ca) microdomains, which are localised areas of increased Ca2+concentration (Rizzuto and Pozzan, 2006). We showed that the density of speci fi c subsets of Ca microdomains selectively and significantly decreased after injury, in ventral optic nerve vulnerable to secondary degeneration (Wells et al., 2012; Lozic et al., 2014). Decreased density of Ca microdomains may be accompanied by an ef fl ux of Ca2+from these microdomains and future NanoSIMS assessments designed to quantify Ca2+release are planned. We have also demonstrated increased immunoreactivity of the GluR1 subunit of the AMPA receptor in ventral optic nerve astrocytes in the fi rst 24 hours after injury (Wells et al., 2012), perhaps contributing to changes in Ca2+fl ux.

Increased Ca2+fl ux has been associated with increased reactive oxygen and nitrogen species and oxidative stress in vitro (Camello-Almaraz et al., 2006; Peng and Jou, 2010). Excess in fl ux of Ca2+leads to perturbations in mitochondrial membrane potential, opening of the mitochondrial permeability transition and release of cytochrome c, which increases production of reactive oxygen species, overwhelms endogenous antioxidant responses and leads to oxidative stress (Kowaltowski et al., 2009; Peng and Jou, 2010). Oxidative stress has been demonstrated as a feature of traumatic brain and spinal cord injury (Park et al., 2004; Carrico et al., 2009). However, it is not yet clear if oxidative stress contributes to secondary degeneration in vivo. We have demonstrated increased immunoreactivity of the antioxidant enzyme manganese superoxide dismutase (MnSOD) in hypertrophic astrocytes, in the first minutes and days after injury (Fitzgerald et al., 2009a; Fitzgerald et al., 2010a), associated with increased reactive species (unpublished). However, antioxidant activity appears inadequate to limit these reactive species and prevent oxidative stress, as we observed structural changes in mitochondria of axons and glia (Cummins et al., 2013) and oxidative damage in optic nerve vulnerable to secondary degeneration, particularly in oligodendrocytes (Fitzgerald et al., 2010a; Szymanski et al., 2013). Protein carbonylation, indicated by increased carboxymethyl lysine (CML), was demonstrated from 1 day after injury (Wells et al., 2012; Szymanski et al., 2013), and we observed oxidative damage to DNA and lipids as well as protein nitration in the fi rst week after injury (unpublished). Oxidative stress is likely exacerbated by in fl ammatory cell in fi ltration, which occurs in the fi rst day after injury in the dorsal injury site and becomes apparent in ventral optic nerve vulnerable to secondary degeneration by day 3 (Fitzgerald et al., 2009a, 2010a). Taken together, our data indicate that spread of reactive species such as H2O2via extracellular release and/ or the astrocytic syncytium likely contributes to the spreading damage of secondary degeneration in neurons and glia.

Dysmyelination during secondary degeneration

When we looked more closely at the cell types exhibiting signs of oxidative stress, we observed that increased CML immunoreactivity was particularly prominent in oligodendrocytes vulnerable to secondary degeneration ((Szymanski et al., 2013) and unpublished), despite reports of resistance of mature oligodendrocytes to oxidative damage (Back et al., 2005). Concurrently, paranodes signi fi cantly lengthened, as did Nodes of Ranvier, and there was greater incidence of abnormal node/ paranode structures (Szymanski et al., 2013). Similar changes have been reported in models of in fl ammatory demyelinating disease, including multiple sclerosis (Lonigro and Devaux, 2009; Oluich et al., 2012). Later after injury myelin became increasingly decompacted, with increased thickness of myelin, due to loosening of myelin lamaellae, and increased numbers of intraperiodic lines (Payne et al., 2011, 2012). These kinds of abnormalities and perturbations in myelin, referred to as dysmyelination, have been reported following spinal cord injury and in demyelinating diseases including multiple sclerosis (Krsulovic et al., 1999; Rosenbluth and Schiff, 2009; Nomura et al., 2013). Visuomotor function, which is signi fi-cantly compromised from one day after injury (unpublished), progressively worsened in the 6 months following partial transection (Payne et al., 2012). Oligodendrocyte precursor cells (OPCs) proliferated and appeared to differentiate and possibly remyelinate axons, at least to some extent. However, there was signi fi cant death of OPCs and their total numbers remained chronically lower in ventral optic nerve vulnerable to secondary degeneration (Payne et al., 2013). Depletion of OPCs may have compromised normal adult myelinogenesis (Young et al., 2013), neuromodulation (Polito and Reynolds, 2005) and myelin repair. We consider it likely that oxidative stress in oligodendrocytes and their precursors contributes to the dysmyelination we observe, as well as associated chronic functional loss. It is interesting to note that following partial optic nerve transection, multifocal electroretinogram responses are reduced in inferior retina vulnerable to secondary degeneration (Chu et al., 2013), perhaps further contributing to loss of visual function.

Strategies to limit dysmyelination during secondary degeneration

A key goal of increasing understanding of the metabolic and structural features of secondary degeneration is to enable rational design of treatment strategies to limit these changes. We have used the relatively CNS speci fi c voltage gated calcium channel inhibitor lomerizine (Hara et al., 1999) as a strategy to limit excess Ca2+fl ux, and potentially oxidative stress, during secondary degeneration. While lomerizine reduced necrotic and to a lesser extent apoptotic death of retinal ganglion cells vulnerable to secondary degeneration (Fitzgerald et al., 2009a; Fitzgerald et al., 2009b), it did not fully restore visual function (Fitzgerald et al., 2009a; Selt et al., 2010). More recently we have combined lomerizine with additional Ca2+channel inhibitors: the highly soluble AMPA receptor antagonist YM872 (also known as zonampanel or INQ) (Atsumi et al., 2003; Furukawa et al., 2003); and the P2X7receptor antagonist oxATP (Wang et al., 2004; Matute et al., 2007). Only treatment with all three of the Ca2+channel inhibitors in combination reduced myelin decompaction, lengthening of Nodes of Ranvier and CML immunoreactivity (indicative of reduced oxidative stress) in oligodendroglia of ventral optic nerve (Savigni et al., 2013). The combination of three Ca2+channel inhibitors also preserved visual function following partial optic nerve transection (Savigni et al., 2013). From this work we can conclude that inhibiting multiple Ca2+permeable receptors is bene fi cial for preventing dysmyelination and preserving function in white matter vulnerable to secondary degeneration. However, bene fi cial effects may not be due solely to reduced Ca2+in fl ux from the extracellular space per se. Inhibition of downstream signalling pathways of individual receptors, such as those leading to calpain mediated axonal degeneration (Thompson et al., 2010), and/or resultant reductions in release from intracellular Ca2+stores (Stirling et al., 2014) may also contribute to beneficial effects. Furthermore, we have not yet ascertained whether it is inhibition of Ca2+permeable receptors in oligodendrocytes, OPCs and/or other cell types, such as astrocytes, neuronal somata and/ or axons, or even photoreceptors, which is bene fi cial.

We are also pursuing anti-oxidant strategies in an effort to reduce dysmyelination due to secondary degeneration. Irradiation with red/near-infrared light (R/NIR-IT, 630-1,000 nm) was developed as a therapeutic strategy for the treatment of a range of injuries and diseases, following observations of bene fi cial effects on minor wound healing in space (Whelan et al., 2001). Speci fi c to the nervous system, bene fi cial effects have been reported following retinal degeneration (Natoli et al., 2010; Albarracin et al., 2011), CNS injury (Byrnes et al., 2005), stroke (Lapchak et al., 2007) and peripheral nerve damage (Rochkind et al., 2009; Ishiguro et al., 2010), as summarized in our recent review (Fitzgerald et al., 2013). While there is controversy regarding the mechanism of action of R/ NIR-IT, one hypothesis is that it acts by improving oxidative metabolism and reducing oxidative stress. The enzyme cytochrome c oxidase, complex IV of the electron transport chain, is proposed to act as a photoacceptor for irradiation at these wavelengths, with absorption spectra matching efficacious wavelengths (Moody, 2005; Wong-Riley et al., 2005). Specifically, irradiation is thought to lead to activation via changes in the oxidation-reduction state of this enzyme (Karu et al., 2008).

We have demonstrated that 670 nm R/NIR-IT delivered by light emitting diode (LED) array increased cytochrome c oxidase activity in optic nerve vulnerable to secondary degeneration (Szymanski et al., 2013). This was accompanied by reduced MnSOD immunoreactivity in astrocytes (Fitzgerald et al., 2010b), reduced incidence of mitochondrial autophagic pro fi les (Cummins et al., 2013), rescue of node/paranode abnormalities and preservation of visual function (Fitzgerald et al., 2010b; Szymanski et al., 2013). Nevertheless scepticism regarding ef fi cacy of R/NIR-IT as a treatment for CNS injury remains, largely due to uncertainty regarding penetrance of the irradiation and lack of consensus on optimal treatment parameters, even within a single type of CNS injury (Fitzgerald et al., 2013). Our current efforts are focussed on developing an optimal R/NIR-IT treatment protocol for prevention of dysmyelination during secondary degeneration following partial optic nerve transection in vivo and conducting multi-centre comparative assessments of ef fi cacy of a single R/NIR-IT treatment paradigm across multiple CNS injury types.

Additional strategies we are pursuing to limit dysmyelination and functional loss due to secondary degeneration following neurotrauma include use of nanotechnologies to deliver rationally designed inhibitors and anti-oxidants to areas of nerve speci fi cally vulnerable to secondary degeneration. We have demonstrated anti-oxidant capacity of phospholipid calix[4]arene formulations in vitro (James et al., 2013) and developed multimodal polymeric nanoparticles, functionalised with magnetite nanoparticles and fl uorescent dyes for tracking by magnetic resonance imaging and fluorescence microscopy respectively, for delivery of therapeutics (Evans et al., 2011). We have shown effective release of lomerizine from these multimodal nanoparticles (Evans et al., 2012) and demonstrated lack of toxicity following injection of our nanoparticles into a partial optic nerve injury site (Harrison et al., 2012). Polymeric nanoparticles have the potential to safely deliver effective anti-oxidant treatment strategies to specific cell types vulnerable to secondary degeneration, overcoming solubility and delivery limitations, and we are currently undertaking studies to assess their efficacy in this regard.

Summary and conclusions

The progression of secondary degeneration following partial optic nerve transection is characterised by initial, rapid onsetalterations to Ca2+distributions and increases in indicators of oxidative stress, particularly in astrocytes. Reactive species and altered Ca2+fl ux may spread to ventral optic nerve vulnerable to secondary degeneration via the astrocytic syncytium. Oxidative stress in oligodendrocytes and alterations to node/paranode structure are evident by 24 hours after injury in ventral optic nerve vulnerable to secondary degeneration, before detection of inflammatory cell infiltration at 3 days. OPC numbers are also reduced from 3 days, despite proliferation of these cells. While retinal ganglion cell axonal loss is evident in ventral optic nerve by 7 days, secondary death of retinal ganglion cell somata is not detected until 2 weeks after injury and is followed by continued axonal swelling and decompaction of myelin surrounding remaining vulnerable axons. Chronic functional loss persists until at least 6 months following injury. Treatment strategies including combinations of Ca2+channel inhibitors and R/NIR-IT have been shown to limit oxidative stress, dysmyelination and functional losses of secondary degeneration. However, it is likely that multi-faceted combinatorial treatment strategies will be required to limit the many aspects of damage during secondary degeneration, especially in more complex models and in patients suffering from neurotrauma.

Melinda Fitzgerald

Experimental and Regenerative Neurosciences, School of Animal Biology, The University of Western Australia, Hackett Drive, Crawley, WA 6009, Australia

Albarracin R, Eells J, Valter K (2011) Photobiomodulation protects the retina from light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci 52:3582-3592.

Atsumi T, Hoshino S, Furukawa T, Kobayashi S, Asakura T, Takahashi M, Yamamoto Y, Teramoto A (2003) The glutamate AMPA receptor antagonist, YM872, attenuates regional cerebral edema and IgG immunoreactivity following experimental brain injury in rats. Acta Neurochir Suppl 86:305-307.

Back SA, Luo NL, Mallinson RA, O’Malley JP, Wallen LD, Frei B, Morrow JD, Petito CK, Roberts CT, Jr., Murdoch GH, Montine TJ (2005) Selective vulnerability of preterm white matter to oxidative damage de fi ned by F2-isoprostanes. Ann Neurol 58:108-120.

Blair M, Pease ME, Hammond J, Valenta D, Kielczewski J, Levkovitch-Verbin H, Quigley H (2005) Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci 46:884-890.

Byrnes KR, Waynant RW, Ilev IK, Wu X, Barna L, Smith K, Heckert R, Gerst H, Anders JJ (2005) Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury. Lasers Surg Med 36:171-185.

Camello-Almaraz MC, Pozo MJ, Murphy MP, Camello PJ (2006) Mitochondrial production of oxidants is necessary for physiological calcium oscillations. J Cell Physiol 206:487-494.

Carrico KM, Vaishnav R, Hall ED (2009) Temporal and spatial dynamics of peroxynitrite-induced oxidative damage after spinal cord contusion injury. J Neurotrauma 26:1369-1378.

Chu PH, Li HY, Chin MP, So KF, Chan HH (2013) Effect of lycium barbarum (wolfberry) polysaccharides on preserving retinal function after partial optic nerve transection. PLoS One 8:e81339.

Cummins N, Bartlett CA, Archer M, Bartlett E, Hemmi JM, Harvey AR, Dunlop SA, Fitzgerald M (2013) Changes to mitochondrial ultrastructure in optic nerve vulnerable to secondary degeneration in vivo are limited by irradiation at 670 nm. BMC Neurosci 14:98.

Evans CW, Fitzgerald M, Clemons TD, House MJ, Padman BS, Shaw JA, Saunders M, Harvey AR, Zdyrko B, Luzinov I, Silva GA, Dunlop SA, Iyer KS (2011) Multimodal Analysis of PEI-Mediated Endocytosis of Nanoparticles in Neural Cells. Acs Nano 5:8640-8648.

Evans CW, Latter MJ, Ho D, Peerzade SAMA, Clemons TD, Fitzgerald M, Dunlop SA, Iyer KS (2012) Multimodal and multifunctional stealth polymer nanospheres for sustained drug delivery. New J Chem 36: 1457-1462.

Farkas O, Povlishock JT (2007) Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res 161:43-59.

Fehlings MG, Vaccaro A, Wilson JR, Singh A, D WC, Harrop JS, Aarabi B, Shaffrey C, Dvorak M, Fisher C, Arnold P, Massicotte EM, Lewis S, Rampersaud R (2012) Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One 7:e32037.

Fitzgerald M, Bartlett CA, Evill L, Rodger J, Harvey AR, Dunlop SA (2009a) Secondary degeneration of the optic nerve following partial transection: the bene fi ts of lomerizine. Exp Neurol 216:219-230.

Fitzgerald M, Bartlett CA, Harvey AR, Dunlop SA (2010a) Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study. J Neurotrauma 27:439-452.

Fitzgerald M, Bartlett CA, Payne SC, Hart NS, Rodger J, Harvey AR, Dunlop SA (2010b) Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve. J Neurotrauma 27:2107-2119.

Fitzgerald M, Hodgetts S, Van Den Heuvel C, Natoli R, Hart NS, Valter K, Harvey AR, Vink R, Provis J, Dunlop SA (2013) Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders. Rev Neurosci 24:205-226.

Fitzgerald M, Payne SC, Bartlett CA, Evill L, Harvey AR, Dunlop SA (2009b) Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine. Invest Ophthalmol Vis Sci 50:5456-5462.

Furukawa T, Hoshino S, Kobayashi S, Asakura T, Takahashi M, Atsumi T, Teramoto A (2003) The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor de fi cits after experimental brain injury in rats. J Neurotrauma 20:269-278.

Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A (2007) Glia: the fulcrum of brain diseases. Cell Death Differ 14:1324-1335.

Hara H, Shimazawa M, Sasaoka M, Yamada C, Iwakura Y, Sakai T, Maeda Y, Yamaguchi T, Sukamoto T, Hashimoto M (1999) Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood fl ow in rats and dogs. Clin Exp Pharmacol Physiol 26:870-876.

Harrison J, Bartlett CA, Cowin G, Nicholls PK, Evans CW, Clemons TD, Zdyrko B, Luzinov IA, Harvey AR, Iyer KS, Dunlop SA, Fitzgerald M (2012) In vivo imaging and biodistribution of multimodal polymeric nanoparticles delivered to the optic nerve. Small 8:1579-1589.

Ishiguro M, Ikeda K, Tomita K (2010) Effect of near-infrared light-emitting diodes on nerve regeneration. J Orthop Sci 15:233-239.

James E, Eggers PK, Harvey AR, Dunlop SA, Fitzgerald M, Stubbs KA, Raston CL (2013) Antioxidant phospholipid calix[4]arene mimics as micellular delivery systems. Org Biomol Chem 11:6108-6112.

Karu TI, Pyatibrat LV, Kolyakov SF, Afanasyeva NI (2008) Absorption measurements of cell monolayers relevant to mechanisms of laser phototherapy: reduction or oxidation of cytochrome c oxidase under laser radiation at 632.8 nm. Photomed Laser Surg 26:593-599.

Khodorov B (2004) Glutamate-induced deregulation of calcium homeostasis and mitochondrial dysfunction in mammalian central neurones. Prog Biophys Mol Biol 86:279-351.

Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE (2009) Mitochondria and reactive oxygen species. Free Radic Biol Med 47:333-343.

Krsulovic J, Couve E, Roncagliolo M (1999) Dysmyelination, demyelination and reactive astrogliosis in the optic nerve of the taiep rat. Biol Res 32:253-262.

Lapchak PA, Salgado KF, Chao CH, Zivin JA (2007) Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: an extended therapeutic window study using continuous and pulse frequency delivery modes. Neuroscience 148:907-914.

Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D’Anna SA, Kerrigan D, Pease ME (2001) Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 42:975-982.

Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF (2003) A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci 44:3388-3393.

Lonigro A, Devaux JJ (2009) Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 132:260-273.

Lozic I, Bartlett CA, Shaw JA, Iyer KS, Dunlop SA, Kilburn MR, Fitzgerald M (2014) Changes in subtypes of Ca microdomains following partial injury to the central nervous system. Metallomics 6:455-464.

Matute C, Torre I, Perez-Cerda F, Perez-Samartin A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodriguez-Antiguedad A, Sanchez-Gomez M, Domercq M (2007) P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27:9525-9533.

Moody DJ (2005) Speci fi c extinction spectrum of oxidised cytochrome c oxidase (520 nm - 999 nm) h [Online]. Biomedical Optics Research Laboratory UCL Department of Medical Physics and Bioengineering.Available: http://www.ucl.ac.uk/medphys/research/borl/intro/ spectra [Accessed 11/04/2014].

Natoli R, Zhu Y, Valter K, Bisti S, Eells J, Stone J (2010) Gene and noncoding RNA regulation underlying photoreceptor protection: microarray study of dietary antioxidant saffron and photobiomodulation in rat retina. Mol Vis 16:1801-1822.

Nomura T, Bando Y, Bochimoto H, Koga D, Watanabe T, Yoshida S (2013) Three-dimensional ultra-structures of myelin and the axons in the spinal cord: application of SEM with the osmium maceration method to the central nervous system in two mouse models. Neurosci Res 75:190-197.

Oluich LJ, Stratton JA, Xing YL, Ng SW, Cate HS, Sah P, Windels F, Kilpatrick TJ, Merson TD (2012) Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J Neurosci 32:8317-8330.

Park E, Velumian AA, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754-774.

Payne SC, Bartlett CA, Harvey AR, Dunlop SA, Fitzgerald M (2011) Chronic swelling and abnormal myelination during secondary degeneration after partial injury to a central nervous system tract. J Neurotrauma 28:1077-1088.

Payne SC, Bartlett CA, Harvey AR, Dunlop SA, Fitzgerald M (2012) Myelin sheath decompaction, axon swelling, and functional loss during chronic secondary degeneration in rat optic nerve. Invest Ophthalmol Vis Sci 53:6093-6101.

Payne SC, Bartlett CA, Savigni DL, Harvey AR, Dunlop SA, Fitzgerald M (2013) Early proliferation does not prevent the loss of oligodendrocyte progenitor cells during the chronic phase of secondary degeneration in a CNS white matter tract. PLoS One 8:e65710.

Peng TI, Jou MJ (2010) Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 1201:183-188.

Polito A, Reynolds R (2005) NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat 207:707-716.

Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S (2004) Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15:415-436.

Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev 86: 369-408.

Rochkind S, Geuna S, Shainberg A (2009) Chapter 25: Phototherapy in peripheral nerve injury: effects on muscle preservation and nerve regeneration. Int Rev Neurobiol 87:445-464.

Rosenbluth J, Schiff R (2009) Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: implications for the mechanism of central nervous system myelin formation. J Neurosci Res 87: 956-963.

Savigni DL, O’Hare Doig RL, Szymanski CR, Bartlett CA, Lozic I, Smith NM, Fitzgerald M (2013) Three Ca channel inhibitors in combination limit chronic secondary degeneration following neurotrauma. Neuropharmacology 75C:380-390.

Selt M, Bartlett CA, Harvey AR, Dunlop SA, Fitzgerald M (2010) Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine. Brain Res Bull 81:467-471.

Stirling DP, Cummins K, Wayne Chen SR, Stys P (2014) Axoplasmic reticulum Ca(2+) release causes secondary degeneration of spinal axons. Ann Neurol 75:220-229.

Szymanski CR, Chiha W, Morellini N, Cummins N, Bartlett CA, O’Hare Doig RL, Savigni DL, Payne SC, Harvey AR, Dunlop SA, Fitzgerald M (2013) Paranode abnormalities and oxidative stress in optic nerve vulnerable to secondary degeneration: modulation by 670 nm light treatment. PLoS One 8(6):e66448.

Thompson SN, Carrico KM, Mustafa AG, Bains M, Hall ED (2010) A pharmacological analysis of the neuroprotective ef fi cacy of the brainand cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J Neurotrauma 27:2233-2243.

Tretter L, Takacs K, Kover K, Adam-Vizi V (2007) Stimulation of H(2) O(2) generation by calcium in brain mitochondria respiring on alpha-glycerophosphate. J Neurosci Res 85:3471-3479.

Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, Nedergaard M (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821-827.

Wells J, Kilburn MR, Shaw JA, Bartlett CA, Harvey AR, Dunlop SA, Fitzgerald M (2012) Early in vivo changes in calcium ions, oxidative stress markers, and ion channel immunoreactivity following partial injury to the optic nerve. J Neurosci Res 90:606-618.

Whelan HT, Smits RL, Jr., Buchman EV, Whelan NT, Turner SG, Margolis DA, Cevenini V, Stinson H, Ignatius R, Martin T, Cwiklinski J, Philippi AF, Graf WR, Hodgson B, Gould L, Kane M, Chen G, Caviness J (2001) Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg 19:305-314.

Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT (2005) Photobiomodulation directly bene fi ts primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem 280:4761-4771.

Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D, Tohyama K, Richardson WD (2013) Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77: 873-885.

Melinda Fitzgerald, Ph.D., Experimental and Regenerative Neurosciences, School of Animal Biology, The University of Western Australia, Hackett Drive, Crawley, WA 6009, Australia,

10.4103/1673-5374.135307 http://www.nrronline.org/

lindy.fitzgerald@uwa.edu.au.

Acknowledgments: Fitzgerald M acknowledges financial support from the Neurotrauma Research Program of Western Australia, an initiative of the Road Safety Council of Western Australia. Part of this work has been funded through the Road Trauma Trust Account, Western Australia, but does not reflect views or recommendations of the Road Safety Council. MF is also currently supported by National Health & Medical Research Council of Australia (NHMRC) Project Grant APP1061791.

Accepted: 2014-04-30

Fitzgerald M. Strategies to limit dysmyelination during secondary degeneration following neurotrauma. Neural Regen Res. 2014;9(11)：1096-1099.